The FDA approves the first generic versions of Singulair for use in adults and children to...
The FDA approves the first generic versions of Singulair for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies. Endo Pharmaceuticals (ENDP +3.2%), Mylan (MYL +4.2%) and Teva Pharmaceuticals (TEVA -0.6%) have all been given the go-ahead.
From other sites
at Zacks.com (Mar 17, 2015)
at Zacks.com (Mar 12, 2015)
at MarketWatch.com (Mar 11, 2015)
at Zacks.com (Mar 3, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs